Adenoma: Clinical Trials

17 trials for Adenoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 unknown, 5 completed, 4 terminated, 1 recruiting. 17 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 417Unknown 7, Completed 5, Terminated 4, Recruiting 1

Follow Adenoma: new trials by email Literature Review of Adenoma trials Research Report on Adenoma

Trials (filtered) newest first · largest first

All 17 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Metabolic Outcomes in Patients With Prolactinomas Under Dopamine Agonist Treatment
Cabergoline (Dopamine Agonist) - Prolactinoma
Phase 4RecruitingUniversity Hospital, Basel, Switzerland602025-09-162025-09-23
Does Fluorescence With or Without Indocyanine Green Improve Parathyroid Identification and Preservation
Indocyanine green, SPY Portable Handheld Imaging - Parathyroid Dysfunction, Adenoma
Phase 4TerminatedUniversity of Alabama at Birmingham4172024-04-112026-05-06
Folinic Acid for Prevention of Pemetrexed-induced Toxicity
Folinic acid - NSCLC, Mesothelioma
Phase 4UnknownAmphia Hospital502023-02-062023-08-24
Azithromycin Treatment for Readthrough of APC Gene Stop Codon Mutations in Familial Adenomatous Polyposis
Azithromycin Tablets - Familial Adenomatous Polyposis
Phase 4UnknownTel-Aviv Sourasky Medical Center102020-08-012020-07-01
A Comparative Study Between Regional Anesthesia in Thoracoscopes and the Conventional General Anesthesia
Thoracic Epidural Anesthesia, General Anesthesia with One Lung Ventilation - Pleural Effusion, Malignant, Pleural Mesothelioma
Phase 4UnknownMohamed Reda Ashour402020-01-152021-10-14
PRolaCT - Three Prolactinoma RCTs
Endoscopic trans-sphenoidal adenoma resection, Dopamine Agonists - Prolactinoma, Prolactin-Producing Pituitary Tumor
Phase 4UnknownLeiden University Medical Center8802019-06-212020-07-20
Dose Individualization of Pemetrexed - IMPROVE-II
Pemetrexed - Non Small Cell Lung Cancer, Mesothelioma
Phase 4TerminatedRadboud University Medical Center812019-02-012022-05-13
Dose Individualization of Pemetrexed - IMPROVE-I
Pemetrexed + oral folinic acid rescue - Non Small Cell Lung Cancer, Mesothelioma
Phase 4CompletedRadboud University Medical Center62019-02-012024-12-17
Dose Individualization of Pemetrexed - IMPROVE-III
Pemetrexed - Non Small Cell Lung Cancer, Mesothelioma
Phase 4CompletedRadboud University Medical Center102019-02-012022-05-10
Erythromycin Treatment for Readthrough of APC Gene Stop Codon Mutation in Familial Adenomatous Polyposis-minors' Adjusted Version
Erythromycin - FAP-Familial Adenomatous Polyposis
Phase 4Unknownmichal roll152015-06-012015-02-03
Erythromycin Treatment for Readthrough of APC Gene Stop Codon Mutations in Familial Adenomatous Polyposis
Erythromycin - FAP-Familial Adenomatous Polyposis
Phase 4Unknownmichal roll202014-06-012014-06-26
Prophylactic Octreotide to Prevent Post Duodenal EMR and Ampullectomy Bleeding
octreotide, No Octreotide - Adenoma
Phase 4TerminatedAdventHealth332014-03-012020-07-16
A Study Of The Efficacy And Safety Of Sunitinib In Patients With Advanced Well-Differentiated Pancreatic Neuroendocrine Tumors
sunitinib - Well-differentiated Pancreatic Neuroendocrine Tumor
Phase 4CompletedPfizer1062012-06-062019-07-30
Clinical Effectiveness of Serum Chromogranin A Levels on Diagnostic of Pancreatic Neuroendocrine Tumors
Chromogranin A - Non Functioning Pancreatic Endocrine Tumor
Phase 4UnknownAsan Medical Center1112012-06-012016-05-03
Comparative Study of Postprocessing Imaging Systems for Diminutive Colonic Polyps
Observation using NBI system, Observation using i-Scan system - Diminutive Colon Polyp, Adenomatous Polyp
Phase 4CompletedSoon Chun Hyang University1422010-05-012011-09-27
Endoscopy Nurse Participation in Adenoma Detection Rate During Colonoscopy
standard of care colonoscopy - Polyp, Adenomatous Polyp
Phase 4CompletedSoon Chun Hyang University8442010-05-012011-02-17
A Study of Rofecoxib in Familial Adenomatous Polyposis (FAP) (0966-205)(TERMINATED)
MK0966; rofecoxib / Duration of Treatment: 24 weeks, Comparator: placebo / Duration of Treatment: 24 weeks - Adenomatous Polyposis Coli
Phase 4TerminatedMerck Sharp & Dohme LLC622002-08-062019-09-20

Narrower conditions

Adenomatous Polyposis Coli (4)  ·  Mesothelioma (4)  ·  Carcinoma, Non-Small-Cell Lung (3)  ·  Adenomatous Polyps (2)  ·  Prolactinoma (2)  ·  Adenoma, Islet Cell (1)  ·  Cancer Pain (1)  ·  Carcinoma (1)  ·  Disease (1)  ·  Empyema, Pleural (1)  ·  Hemothorax (1)  ·  Hyperprolactinemia (1)  ·  Lung Diseases (1)  ·  Mesothelioma, Malignant (1)

Broader conditions

Neoplasms by Histologic Type (17)  ·  Neoplasms, Glandular and Epithelial (17)  ·  Neoplasms (16)  ·  Neoplasms by Site (13)  ·  Digestive System Diseases (6)  ·  Digestive System Neoplasms (6)  ·  Endocrine System Diseases (5)  ·  Neoplasms, Mesothelial (5)  ·  Thoracic Neoplasms (5)  ·  Adenomatous Polyps (4)  ·  Colonic Diseases (4)  ·  Colorectal Neoplasms (4)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (4)  ·  Endocrine Gland Neoplasms (4)

Interventions

Pemetrexed (3)  ·  Dopamine Agonists (2)  ·  Erythromycin (2)  ·  Anesthesia, General (1)  ·  Azithromycin (1)  ·  Cabergoline (1)  ·  Chromogranin A (1)  ·  Clinical Trials, Phase I as Topic (1)  ·  Drug Evaluation (1)  ·  Duration of Therapy (1)  ·  Indocyanine Green (1)  ·  Leucovorin (1)  ·  Narrow Band Imaging (1)  ·  Octreotide (1)  ·  One-Lung Ventilation (1)

Sponsors

Radboud University Medical Center (3)  ·  Soon Chun Hyang University (2)  ·  michal roll (2)  ·  AdventHealth (1)  ·  Amphia Hospital (1)  ·  Asan Medical Center (1)  ·  Leiden University Medical Center (1)  ·  Merck Sharp & Dohme LLC (1)  ·  Mohamed Reda Ashour (1)  ·  Pfizer (1)  ·  Tel-Aviv Sourasky Medical Center (1)  ·  University Hospital, Basel, Switzerland (1)  ·  University of Alabama at Birmingham (1)

Countries

Netherlands (5)  ·  United States (3)  ·  Israel (2)  ·  South Korea (2)  ·  Australia (1)  ·  Belgium (1)  ·  China (1)  ·  Czechia (1)  ·  Egypt (1)  ·  France (1)  ·  Hungary (1)  ·  India (1)  ·  Italy (1)  ·  Japan (1)  ·  Norway (1)

Top investigators

Rob ter Heine, PhD (3)  ·  Chang Kyun Lee, MD, PhD (2)  ·  Ahmed F Koraitim, MD (1)  ·  Cihan Atila, Dr. (1)  ·  Hany H El Sayed, Professor (1)  ·  Herbert Chen, MD (1)  ·  Nienke R Biermasz, MD, prof. (1)  ·  Revital Kariv, MD (1)  ·  Revital Kariv, MD. (1)  ·  Rina Rosin-Arbeseld, Ph.D (1)  ·  Rina Rosin-Arbeseld, Ph.D. (1)  ·  Robert Hawes, MD (1)

Results publications

PMID 35048355, PMID 36053283, PMID 20018966, PMID 21762907, PMID 21889137, PMID 33411058, PMID 34181276, PMID 34563236, PMID 36413252, PMID 40421804

NIH funding

2025 (1)